ARTICLE | Clinical News
Autologous CD34+ cells: Phase I/II data
August 5, 2013 7:00 AM UTC
The open-label, Italian Phase I/II TIGET-MLD trial in 3 evaluable pre-symptomatic patients with evidence of late infantile MLD showed that IV infusions of autologous CD34+ cells transfected with a len...